Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E7820 plus FOLFIRI in second-line mCRC
NCT01133990Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2010
- Primary completion
- Feb 2011
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 2 trial of e7820 in colorectal cancer (CRC), sponsored by Eisai Co., Ltd.. Started Mar 2010; status: terminated.
02
Drugs
e7820
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01133990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01133990.